ADGM
Adagio Medical Holdings, Inc.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R Apr 27 Adagio Medical announced positive pivotal results from its FULCRUM-V…
- A Jun 3 LUCID CAPITAL MARKETS initiates
- E Aug 4 Trading halt: Halt Resumed: ADGM — trading resumed after LUDP (Volatilit…
- X Aug 14 Short interest jumps 446.4% to 325.4K
- X Sep 15 Short interest jumps 59.3% to 412.8K
- R Sep 23 Adagio Medical is laying off 58% of its workforce (25 of 43 employee…
- X Sep 30 Short interest jumps 211.8% to 1.29M
- R Oct 1 A holder of Adagio Medical's 13% Senior Secured Convertible Notes co…
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- InstitutionsMIXED
Q2 2026: 3 added (0 new), 1 trimmed or exited.
- Short sellersBUILDING
Short interest +211.8% to 1.29M shares. 1.0 days to cover, ≈5.8% of shares.
- TrendDOWNTREND
72% below its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | DOUBLED | $71.0K |
| GEODE CAPITAL MANAGEMENT, LLC | TRIM | $51.5K |
| NORTHERN TRUST CORP | ADD | $20.1K |
| CITIGROUP INC | DOUBLED | $8.6K |
| GEODE CAPITAL MANAGEMENT, LLC | ADD | $144.0K |
| VANGUARD GROUP INC | DOUBLED | $82.6K |
| GEODE CAPITAL MANAGEMENT, LLC | ADD | $71.1K |
| BANK OF AMERICA CORP /DE/ | DOUBLED | $12.0K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
last action Jun 2026| Date | Firm | Rating |
|---|---|---|
| Jun 3, 2026 | LUCID CAPITAL MARKETS INITIATE | Buy |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 16, 2026 | Moran Timothy P. Director | AWARD | 30,000 sh |
| Jun 16, 2026 | Salmon Sean Director | AWARD | 30,000 sh |
| Jun 16, 2026 | MISHAN ORLY Director | AWARD | 100,000 sh |
| Jun 16, 2026 | GARDINER SANDRA A. Director | AWARD | 30,000 sh |
| Jun 16, 2026 | Cox James L Director | AWARD | 30,000 sh |
| Jun 16, 2026 | Mirsaeedi-Farahani Keyvan Director | AWARD | 30,000 sh |
| Mar 6, 2026 | Kaster Deborah Chief Financial Officer | AWARD | 490,500 sh |
| Mar 6, 2026 | Usen Todd Chief Executive Officer | AWARD | 800,000 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data — subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data — subscribers only | |||
| Next Q | 🔒 Fresh data — subscribers only | |||
| Current FY | 🔒 Fresh data — subscribers only | |||
| Next FY | 🔒 Fresh data — subscribers only | |||
Short side
FINRA· Sep 30, 2026| Aug 4, 2026 | Volatility Pause | Resumed |
| Aug 4, 2026 | Volatility Pause | Resumed |
SecBot reports
10 filings · 4 bullish · 4 bearish · 2 neutral- NEUTRAL DEF 14AOct 13, 2026
Adagio Medical Holdings, Inc. is holding a special meeting on October 23, 2026, to seek…
Monitor the special meeting outcome on October 23, 2026, for the reverse stock split approval. If passed, the Board may implement a split at any ratio up to 1-for-500 within 12 months. The stock…
- BEARISH 8-KOct 1, 2026
A holder of Adagio Medical's 13% Senior Secured Convertible Notes converted $776,111 of principal…
The conversion at deeply discounted prices signals that noteholders are rushing to exit before a potential restructuring or bankruptcy. The strategic alternatives review (announced Sep 23) combined…
- BEARISH 8-KSep 23, 2026
Adagio Medical is laying off 58% of its workforce (25 of 43 employees) and initiating a formal…
The strategic review and deep workforce cut indicate the company is running out of cash before FDA approval on vCLAS. The lowered conversion price on the 13% notes will almost certainly trigger…
- BEARISH 8-KAug 11, 2026
Adagio Medical reported Q2 2026 results with a net loss of $6.7M ($0.30/share), wider than the…
Monitor for capital raise announcements or warrant exercises to extend runway. The PMA submission is a key catalyst, but FDA review timeline is uncertain. The stock is likely to remain under…
All ADGM filing & press-release reports (10)
- DEF 14A reportOct 13, 2026
- 8-K reportOct 1, 2026
- 8-K reportSep 23, 2026
- 8-K reportAug 11, 2026
- 10-K/A reportJul 13, 2026
- 8-K reportMay 21, 2026
- 8-K reportMay 12, 2026
- 8-K reportApr 27, 2026
- 8-K reportApr 8, 2026
- EFFECT reportApr 6, 2026